Leslie Stolz
General Counsel bei VERVE THERAPEUTICS, INC.
Aktive Positionen von Leslie Stolz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERVE THERAPEUTICS, INC. | General Counsel | 01.06.2019 | - |
Karriereverlauf von Leslie Stolz
Ehemalige bekannte Positionen von Leslie Stolz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | 01.01.2018 |
Ausbildung von Leslie Stolz
Duke University | Doctorate Degree |
Villanova University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
General Counsel | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VERVE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Leslie Stolz
- Erfahrung